INT232662

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.03
First Reported 2007
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.57
Pain Relevance 1.95

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

MS (Homo sapiens)
Pain Link Frequency Relevance Heat
Opioid 74 97.82 Very High Very High Very High
Oxycodone 10 96.00 Very High Very High Very High
Pain 137 93.64 High High
addiction 4 89.32 High High
Physical dependence 1 88.76 High High
Cancer pain 44 85.56 High High
Analgesic 44 82.80 Quite High
Codeine 5 79.12 Quite High
opioid receptor 4 72.76 Quite High
Potency 2 72.08 Quite High
Disease Link Frequency Relevance Heat
Pain 158 93.64 High High
Drug Dependence 1 88.76 High High
Phobia 4 87.96 High High
Cancer Pain 53 85.56 High High
Reprotox - General 3 3 80.12 Quite High
Syndrome 5 45.60 Quite Low
Nociception 9 32.36 Quite Low
Hypersensitivity 1 30.96 Quite Low
Sleep Disorders 11 23.20 Low Low
Constipation 6 21.88 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
A wide variety of opioids are currently available in the market (Table 2), and are roughly categorized into controlled (or sustained) release (SR), such as MS Contin®, Avinza®, Kadian®, Oxycontin®, Duragesic®, and immediate release (IR) formulations, such as MSIR, Oxycodone, Hydromorphone, Actiq®, etc.
Localization (release) of MS Contin associated with oxycodone and opioid
1) Confidence 0.03 Published 2007 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2386360 Disease Relevance 0.57 Pain Relevance 1.95

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox